Contacts

2300 Corporate Blvd. N.W.
Suite 123
Boca Raton, Florida 33431
Tel 800.998.9964
Fax 561.995.2449

Vicor Press Releases

11/17/08
Vicor Technologies Issues Letter To Shareholders; Discusses Milestones, Progress Towards Commercializing Pd2i Technology For Sudden Cardiac Death, Triage And Heart Rate Variability
11/10/08
Vicor Technologies' Chief Medical Officer Interviewed On National Public Radio; Discusses Technology For Measuring Heart Rate Variability And Sudden Cardiac Death
06/19/08
Vicor Technologies Reviews Positive Developments for its Risk Stratification Device For Sudden Cardiac Death and Collaboration With U.S. Army For Trauma and Emergency Response at Annual Meeting
06/10/08
Vicor Technologies Announces Addition to Scientific Advisory Board
05/29/08
Vicor Technologies Announces Addition to Scientific Advisory Board
05/12/08
Vicor Technologies Announces Additional Positive Clinical Trial Results
04/21/08
Vicor Technologies Announces Conversion of $1,251,200 of Indebtedness Into Equity
04/15/08
Vicor Technologies Announces Addition to Scientific Advisory Board
04/07/08
Vicor Technologies Interviewed By CEOCFO
01/29/08
Vicor Technologies Announces Collaboration Agreement With The U. S. Army For Use Of PD2i Cardiac Analyzer
07/12/07
Vicor Technologies Talks Live On mn1.com About Latest Corporate Developments
07/12/07
Vicor Technologies Retains ROI Group As Investor Relations Counsel
07/10/07
Vicor Technologies Announces Initial Trading Of Its Common Shares Under Symbol: VCRT
04/03/07
Vicor Technologies Announces Completion Of Merger; Clinical Trials For Its Sudden Cardiac Death Risk Stratification Device Continue
11/28/06
Vicor Technologies Initiates Clinical Sites For Pivotal Vital Trial; Enrolls First Two Patients
10/30/06
Vicor Technologies to Present at the Rodman & Renshaw Eighth Annual Healthcare Conference 2006
01/20/05
Vicor Technologies Retains Investment Bank WestPark Capital to Advise on Financings and Strategic Initiatives
11/09/04
Hein J. J. Wellens, M.D. has joined Vicor's Scientific Advisory Board
01/19/04
Mark E. Josephson, M.D. Joins Scientific Advisory Board
09/22/03
Daniel N. Weiss, M.D.,F.A.C.C. Joins Scientific Advisory Board
03/20/03
Vicor Technologies Awarded NIH Grant
01/13/03
Vicor Establishes Relationship with Department of Defense
12/04/02
Vicor Establishes Relationship with Mt. Sinai Medical Center
09/11/02
Vicor's Proprietary Fraction (VPF) Stimulates Urea-Recycling in Non-hibernating Animal
05/22/02
Vicor Technologies Announces New Appointments
04/08/02
Vicor Technologies' Proprietary Fraction (VPF) Extends Successful Results in the Heart
02/22/02
Vicor Technologies' Active Peptide May Be Novel
01/10/02
Vicor Technologies Zeros in on Anti-Stroke Molecule
10/01/01
Vicor Technologies Reports Prevention of Stroke by a Vicor Proprietary Fraction of Molecules
07/10/01
Vicor Technologies Reports Exciting Results Concerning Peptides
05/15/01
Vicor Technologies Signs Agreement with Genomic Solutions
03/20/01
Vicor Technologies Signs Agreement with Calvert Laboratories